Aviragen Therapeutics to explore strategic alternatives

This article was originally published here

Aviragen Therapeutics intends to explore a range of strategic alternatives including a business combination, merger, in-licensing of complementary products, acquisition or any other value-building transaction.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply